US Long Acting Analgesic Industry – A Global Market Overview (2017-2021) (Avail a 10% off)
The latest report titled “US Long Acting Analgesic Market Research Report 2017-2021” divided by product type, applications, industry verticals, and research regions build an in-depth explanation of the perspectives, and comprehensive market statistics. The report presents a thorough analysis of the US Long Acting Analgesic Market covering key trends, deployment models, challenges, market drivers, future roadmap, ecosystem player profiles, strategies, and value chain.
Purchase This Report (800$ only) at:
Top Leading Key Players: Pacira Pharmaceutical Inc., Heron Therapeutics Inc. and Fresenius Group.
Scope of the Report
The report entitled The US Long Acting Analgesic Market: Size, Trends & Forecasts (2017-2021), provides analysis of the US analgesics market, with detailed analysis of market size in terms of number of procedures, segments, etc. Further, an analysis of the long acting analgesics in terms of penetration has been done for EXPAREL and HTX-011 along with its respective sales analysis. Under competitive landscape, players in the US analgesics market (both short and long acting analgesics) have been compared on the basis of market capitalization.
Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the long acting analgesics market in the US has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Click the link to get a Sample Copy of the Report:
The US analgesic market can be divided on the basis of type, mode of administration and duration. On the basis of type, the market can be sub segmented into opioid and non opioid. On the basis of mode of administration, the market can be divided into intravenous and locally delivered analgesics. On the basis of duration, the market can be further segmented into long acting and short acting analgesics.
The US long acting analgesic market is expected to increase at high growth rates during the forecast period (2017-2021). The US long acting analgesic market is supported by various growth factors such as increasing elderly population,, increase in use of non opioid analgesics especially in orthopedic procedures and disadvantages of opioids.
However, issues faced by PCRX in the commercialization of EXPAREL is major challenge faced by the market. Upsurge in research and development expenses, low penetration of currently used local analgesics, evolution of multimodal analgesics and long acting analgesics in pipeline are some of the latest trends existing in the market.
Browse the Full Report Description and TOC:
Influence of the US Long Acting Analgesic Market report:
-Comprehensive assessment of all opportunities and risk in the US Long Acting Analgesic Market.
– US Long Acting Analgesic Market recent innovations and major events.
-Detailed study of business strategies for growth of the US Long Acting Analgesic Market -leading players.
-Conclusive study about the growth plot of US Long Acting Analgesic Market for forthcoming years.
-In-depth understanding of US Long Acting Analgesic Market -particular drivers, constraints and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the US Long Acting Analgesic Market.
Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs.
Media Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687